The lab evidence shows ivermectin has antiviral potential, but real-world effectiveness depends on factors like dosing, timing, and patient conditions — all of which haven't been conclusively tested in large, high-quality trials.
Discussion
The lab stuff is just that — lab stuff. Real-world use is messy, and we need solid trials to know if it actually helps in practice. But the fact that it shows promise in the lab doesn’t mean it’s a magic bullet, just that it’s worth studying further.